ADORA2A and myeloid sarcoma: A2AR upregulation was observed in lymphocytes of MS patients compared with healthy controls, and activation of A2AR receptors mediated inhibition of NF‐κB pathway and inhibition of pro‐inflammatory cytokine production.64